An NMR strategy is described for measuring changes in 13 C spin-lattice relaxation times (T 1 ) of ligand molecules, at natural isotopic abundance, upon binding to macromolecules of potentially unlimited size. The rapidly reversible binding nature of a substrate-based inhibitor (BILN127SE, K i ) 5.4 µM) with the NS3 protease domain of the hepatitis C virus has been well documented and has served as an appropriate system for testing the transferred 13 C T 1 concept. 13 C T 1 relaxation, which is sensitive to motions that occur on the pico-to nanosecond time scale, were first measured for free BILN127SE. Upon addition of the protease at a 25:1 inhibitor-to-protease ratio, differential changes in the 13 C T 1 relaxation times of BILN127SE were observed. The equilibrium binding nature of the complex, results in a transfer of T 1 relaxation information of the ligand from the bound to the free state where it is more easily detected. The relative changes in 13 C T 1 relaxation provides a qualitative insight into the site-specific changes in ligand immobilization upon binding to the protease. Comparisons of this dynamics information are made with structural data deduced from 1 H NOESY, line-broadening, J-coupling, and ROESY experiments. The combination of dynamics and structural information should provide medicinal chemists with further opportunities to design more potent, chemically rigidified inhibitors.